Gamida Cell Ltd. (NASDAQ:GMDA) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to Gamida Cell's Conference Call for Third Quarter 2023 Financial Results.
Source: insidermonkey.com
Ronit Simantov News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ronit Simantov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ronit Simantov Today - Breaking & Trending Today
Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting
BOSTON, Nov. 04, 2023 -- Gamida Cell Ltd. , a cell therapy pioneer working to turn cells into powerful therapeutics, today shared new data on the impact of the company’s proprietary nicotinamide ...
Source: marketscreener.com
Gamida Cell Presents New Data on Allogeneic Stem Cell
Data further characterize the mechanism for Gamida Cell’s proprietary nicotinamide (NAM) technology’s expansion and enhancement of cells...
Source: globenewswire.com
Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201
Data show promising early evidence of anti-tumor activity in patients with relapsed/refractory B cell non-Hodgkin lymphoma Full data readout of Phase 1 study expected in Q1 2024 ...
Source: marketscreener.com
Data Published in Transplantation and Cellular Therapy Suggest Antiviral Protection After Transplantation with Gamida Cell's Omisirge® (omidubicel-onlv)
Faster immune reconstitution and decreased rate of post-transplant viral infection in patients transplanted with Omisirge versus umbilical cord blood
Source: marketscreener.com